© 2004 by European Society of Cardiology
Copyright © 2004, European Society of Cardiology
Cross-talk between the survival kinases during early reperfusion: its contribution to ischemic preconditioning
The Hatter Institute and Centre for Cardiology, University College London Hospital, and Medical School, Grafton Way, London WC1E 6DB, UK
* Corresponding author. Tel.: +44-207-380-9776; fax: +44-207-388-5095. Email address: hatter-institute{at}ucl.ac.uk
Objectives: Recruitment of the survival kinase cascades, PI3K–Akt and Raf–MEK1/2–Erk1/2, at the time of reperfusion, following a lethal ischemic insult, may mediate the protection associated with ischemic preconditioning (IPC). The exact interplay between these two kinase cascades in mediating this effect is not clear. We examine the ‘cross-talk’ between these kinase cascades in their contribution to IPC-induced protection. Methods and results: In isolated perfused rat hearts subjected to 35 min of lethal ischemia±ischemic preconditioning, the phosphorylation states of Akt, Erk1/2, p70S6K were determined after 15 min of reperfusion, and infarct size was measured after 120 min of reperfusion. IPC induced a threefold increase in Akt, Erk1/2, and p70S6K phosphorylation, at reperfusion. We found that inhibiting the PI3K–Akt (using LY294008) at reperfusion induced the phosphorylation of Erk1/2–p70S6K, and conversely, that inhibiting the MEK1/2–Erk1/2 pathway (using PD 98059) at reperfusion, induced the phosphorylation of Akt, suggesting ‘cross-talk’ between the two kinase pathways. However, this effect was not accompanied by a reduction in infarct size (43.1±7.2% with LY 294008 and 57.7±7.0% with PD 98059 vs. 46.3±5.8% in control; P=NS), suggesting that both the kinase cascades may need to be activated to mediate IPC-induced protection. IPC reduced the infarct–risk volume ratio to 17.8±2.3% from 46.3±5.8% in control (P<0.01). Inhibiting p70S6K, a kinase situated downstream of both PI3K and Erk1/2, using rapamycin, abolished IPC-induced protection (46.0±7.7% with IPC+RAPA vs. 17.8±2.3% with IPC; P<0.01). Conclusions: We report that, the survival kinase cascades PI3K–Akt and MEK1/2–Erk1/2, which are recruited at the time of reperfusion in response to ischemic preconditioning, exhibit ‘cross-talk’ such that inhibiting one cascade activates the other and vice versa. Furthermore, at the time of reperfusion, these kinase cascades mediate IPC-induced protection, by acting in concert via p70S6K.
KEYWORDS Reperfusion injury; Ischemic preconditioning; Survival kinases; Cross-talk
Time for primary review 7 days
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. L. Strande, M. E. Widlansky, N. E. Tsopanoglou, J. Su, J. Wang, A. Hsu, K. V. Routhu, and J. E. Baker Parstatin: a cryptic peptide involved in cardioprotection after ischaemia and reperfusion injury Cardiovasc Res, July 15, 2009; 83(2): 325 - 334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ban, A. J. Cooper, S. Samuel, A. Bhatti, M. Patel, S. Izumo, J. M. Penninger, P. H. Backx, G. Y. Oudit, and R. G. Tsushima Phosphatidylinositol 3-Kinase {gamma} Is a Critical Mediator of Myocardial Ischemic and Adenosine-Mediated Preconditioning Circ. Res., September 12, 2008; 103(6): 643 - 653. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Suleman, S. Somers, R. Smith, L. H. Opie, and S. C. Lecour Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning Cardiovasc Res, July 1, 2008; 79(1): 127 - 133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Kumar, R. Afeyan, H.-D. Kim, and D. A. Lauffenburger Multipathway Model Enables Prediction of Kinase Inhibitor Cross-Talk Effects on Migration of Her2-Overexpressing Mammary Epithelial Cells Mol. Pharmacol., June 1, 2008; 73(6): 1668 - 1678. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Murphy and C. Steenbergen Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion Injury Physiol Rev, April 1, 2008; 88(2): 581 - 609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. R. Khabbaz, J. Feng, M. Boodhwani, R. T. Clements, C. Bianchi, and F. W. Sellke Nonischemic myocardial acidosis adversely affects microvascular and myocardial function and triggers apoptosis during cardioplegia J. Thorac. Cardiovasc. Surg., January 1, 2008; 135(1): 139 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. d. de Tassigny, A. Berdeaux, R. Souktani, P. Henry, and B. Ghaleh The volume-sensitive chloride channel inhibitors prevent both contractile dysfunction and apoptosis induced by doxorubicin through PI3kinase, Akt and Erk 1/2 Eur J Heart Fail, January 1, 2008; 10(1): 39 - 46. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. V. Cohen, X.-M. Yang, and J. M. Downey The pH Hypothesis of Postconditioning: Staccato Reperfusion Reintroduces Oxygen and Perpetuates Myocardial Acidosis Circulation, April 10, 2007; 115(14): 1895 - 1903. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Schwartz and C. J. Lagranha Ischemic postconditioning during reperfusion activates Akt and ERK without protecting against lethal myocardial ischemia-reperfusion injury in pigs Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1011 - H1018. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. He, H.-T. Cho, W. Li, T. Kawakita, L. Jong, and S. C. G. Tseng Signaling-Transduction Pathways Required for Ex Vivo Expansion of Human Limbal Explants on Intact Amniotic Membrane Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 151 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. V. Solenkova, V. Solodushko, M. V. Cohen, and J. M. Downey Endogenous adenosine protects preconditioned heart during early minutes of reperfusion by activating Akt Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H441 - H449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lecour, N. Suleman, G. A. Deuchar, S. Somers, L. Lacerda, B. Huisamen, and L. H. Opie Pharmacological Preconditioning With Tumor Necrosis Factor-{alpha} Activates Signal Transducer and Activator of Transcription-3 at Reperfusion Without Involving Classic Prosurvival Kinases (Akt and Extracellular Signal-Regulated Kinase) Circulation, December 20, 2005; 112(25): 3911 - 3918. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Mensah, M. M. Mocanu, and D. M. Yellon Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: A potential role for phosphatase and tensin homolog deleted on chromosome ten? J. Am. Coll. Cardiol., April 19, 2005; 45(8): 1287 - 1291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Hausenloy, A. Tsang, M. M. Mocanu, and D. M. Yellon Ischemic preconditioning protects by activating prosurvival kinases at reperfusion Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H971 - H976. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Schulz A new paradigm: cross talk of protein kinases during reperfusion saves life! Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H1 - H2. [Full Text] [PDF]
|
|